According to the latest report by IMARC Group, titled “Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on regenerative medicine market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global regenerative medicine market reached a value of US$ 14.78 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 50.44 Billion by 2027, exhibiting at a CAGR of 22.6% during 2022-2027.
Regenerative medicine refers to a component of biomedical sciences aimed at restoring the structure and function of damaged organs and tissues. It involves the usage of stem cells that are created in laboratories and implanted safely into the body for the regeneration of cartilage, blood vessels, damaged bones, and organs. Cellular and acellular regenerative medicines are generally used in various clinical therapeutic procedures, including immunomodulation, cell, and tissue engineering therapies. In addition, they hold the potential for the effective treatment of several chronic diseases, such as Parkinson’s, Alzheimer’s, cardiovascular disorders (CVDs), osteoporosis, and spinal cord injuries. As a result, regenerative medicine finds widespread applications in hospitals and specialty clinics.
The escalating prevalence of chronic medical ailments and genetic conditions across the globe is among the primary factors driving the regenerative medicine market. Besides this, the rising geriatric population, which is prone to various oncological, dermatological, musculoskeletal, and cardiological disorders, is further augmenting the market growth. Moreover, regenerative medicine minimizes the risk of organ rejection by the body post-transplant and enhances the recovery speed of the patient, which is also catalyzing the global market. Apart from this, various technological advancements in cell-based therapies, including the development of 3D bioprinting techniques and the utilization of artificial intelligence (AI) in the production of these medications, are acting as significant growth-inducing factors. Additionally, the elevating requirement for this component, as it aids in conducting efficient dermatological grafting procedures to treat chronic burns, bone defects, and wounds on the skin, is also stimulating market growth. Furthermore, the extensive research and development (R&D) activities in the field of medical sciences and the expanding healthcare infrastructure are anticipated to propel the regenerative medicine market over the forecasted period.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Allergan PLC (AbbVie Inc.)
- Amgen Inc.
- Baxter International Inc.
- BD (Becton, Dickinson and Company)
- Integra Lifesciences Holdings Corporation
- Medtronic plc
- Mimedx Group Inc.
- Novartis AG
- Osiris Therapeutics Inc. (Smith & Nephew plc)
- Thermo Fisher Scientific Inc
Regenerative Medicine Market Segmentation:
Our report has categorized the market based on region, type, application and end user.
Breakup by Type:
- Stem Cell Therapy
- Tissue Engineering
Breakup by Application:
- Bone Graft Substitutes
- Osteoarticular Diseases
- Central Nervous System
Breakup by End User:
- Specialty Clinics
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800